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Summary
Background: Myocardial perfusion imaging shows various patterns in patients with non-ischemic
dilated cardiomyopathy (DCM). However, inﬂuences of regional abnormalities of myocardial
perfusion or ventricular wall motion on prognosis in DCM patients remains to be clariﬁed.
Accordingly, we investigated a relation between myocardial perfusion patterns and long-term
prognosis in DCM patients.
Methods and results: Sixty-two patients were divided into 2 groups according to patterns of
99mTc-Tetrofosmin scintigraphy, i.e. large focal defects (focal) and minimally impaired perfu-
sion or multiple small defects (non-focal). There were no differences between the 2 groups
in left ventricular (LV) end-diastolic dimensions (63.4± 9.1 and 63.8.4± 7.5mm, respectively)
and LV ejection fraction (30.3± 9.2 and 27.9± 7.8%, respectively), indicating LV systolic dys-
function was comparable between the groups. The focal group had a higher prevalence of brain
natriuretic peptide  200 ng/dl and plasma norepinephrine  500 pg/ml than the non-focal
group (p < 0.05), and had longer QRS durations (p < 0.05). The focal group had non-sustained
ventricular tachycardia (VT) (p < 0.05) on 24-h electrocardiogram recording and a history of
VT/ventricular ﬁbrillation more frequently (p < 0.05), and had higher New York Heart Associa-
tion functional class than the non-focal group (p < 0.05). The mortality was signiﬁcantly higher
in the focal group (56.0%) than in the non-focal group (28.6%) and the survival curves revealed
worse prognosis in the focal group during a follow-up period of 5.3± 2.8 years.
∗ Corresponding author. Tel.: +81 76 434 7297, fax: +81 76 434 5026.
E-mail address: tnozawa@med.u-toyama.ac.jp (T. Nozawa).
914-5087/$ — see front matter © 2010 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
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Conclusions: Non-ischemic DCM patients with focal defects are accompanied by more advanced
heart failure and poor prognosis compared to those with minimally impaired perfusion or multiple
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with Kaplan—Meier event-free survival curves and comparedsmall defects, despite compa
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Introduction
Non-ischemic dilated cardiomyopathy (DCM) is presumed to
affect the myocardium diffusely in association with global
eccentric left ventricular (LV) hypertrophy and reduced LV
ejection fraction (EF). Despite this, regional heterogeneity
of LV function, metabolism, and perfusion have been demon-
strated using echocardiography, left ventriculography, cine
magnetic resonance imaging (MRI) and radionuclide stud-
ies [1—4]. Patients with DCM also show various patterns of
myocardial perfusion imaging [5,6]. The severity of myocar-
dial perfusion abnormality may be related with myocardial
ﬁbrosis [7], while the perfusion defect could be improved by
-blocker therapy [8], suggesting the myocardium in the low
perfusion area is viable. A previous study [9] showed that
patients with a large 201-thallium (201Tl) perfusion defect
had worse prognosis in association with more advanced LV
dysfunction, as compared to those with minimally impaired
perfusion or multiple small defects, while inﬂuences of
wall motion abnormality on prognosis were inconsistent in
relatively short-term follow-up studies, i.e. a study [10]
reported worse prognosis in DCM patients with segmen-
tal wall motion abnormality than in those with diffuse
wall motion abnormality, but the opposite in another study
[11]. Therefore, the purpose of the present study was to
compare clinical characteristics and long-term prognosis of
non-ischemic DCM patients with large, localized myocardial
perfusion defect to those with minimally impaired perfusion
or multiple small perfusion defects.
Methods
Study patients
We performed a retrospective analysis using clinical records
in non-ischemic DCM patients who underwent myocardial
perfusion imaging between June 1996 and May 2006. A blan-
ket agreement of usage of clinical data in observational
studies is obtained from patients. Sixty-two consecutive
patients (43 men and 19 women, mean age 57± 14 years)
who met the following criteria constituted the study group:
LV systolic dysfunction (LVEF < 45%), LV end-diastolic dimen-
sion >50mm on echocardiography and no lumen diameter
stenosis 50% in any of the major epicardial coronary arter-
ies and their branches on coronary angiography. No patients
had a history of myocardial infarction or chest pain sugges-
tive of myocardial ischemia. Patients were excluded if they
had congenital heart disease, valvular heart disease, or gen-
eral systemic disease, but patients with the dilated stage of
hypertrophic cardiomyopathy (HCM) were included.99mTc-labeled myocardial scintigraphy
99mTc-labeled myocardial perfusion imaging was per-
formed within 2 months before or after coronary
w
w
s
U
Ue LV systolic dysfunction.
ology. Published by Elsevier Ireland Ltd. All rights reserved.
ngiography. Planar and single photon emission com-
uted tomography (SPECT) images were acquired 30min
fter intravenous injection of 740MBq of 99mTc-labeled
etrofosmin at rest using a 3-headed gamma camera
Toshiba GCA-9300A/DI, Tokyo, Japan) with a high-resolution
arallel-hole collimator. After transaxial reconstruction
sing a ﬁltered back projection algorithm with Butter-
orth (ﬁlter order 8, cutoff frequency 0.3 cycle/pixel)
nd Ramp ﬁlters, short-axis, vertical and horizontal
ong-axis tomograms were obtained without attenuation
orrections.
Images were interpreted by 2 experienced observers
ho were unaware of the angiographic and echocardio-
raphic results. SPECT images were analyzed on the 17
egments of LV with a 4-point grading scale: 0 = normal
ptake; 1 = equivocal reduction of uptake; 2 =moderate
eduction of uptake; 3 = severe reduction of uptake;
nd 4 = no uptake [12], and summed severity scores
ere calculated. Patients were divided into 2 groups
ccording to the myocardial perfusion patterns; large
efects with the defect size  2 consecutive seg-
ents and grade 2 reduction (focal defect pattern)
nd minimally impaired perfusion (grade 1) or mul-
iple small defects with the size of each defect  1
egment but grade  2 reduction (non-focal defect pat-
ern).
wenty- four-hour electrocardiograph recording
ithin 1 month of myocardial scintigraphy 24-h electrocar-
iograph (ECG) recording was performed. ECG was analyzed
sing a Holter analysis system (DMW-900, Fukuda Denshi,
okyo, Japan). Special attention was given to presence
f ventricular tachyarrhythmias. Non-sustained ventricular
achycardia (VT) was deﬁned as triplet or more of premature
entricular contractions, and sustained VT, as VT lasting 30 s
r more. A history of sustained VT or ventricular ﬁbrillation
VF) was assessed using a clinical record.
tatistics
he results are expressed as mean± SD. Variables between
he groups were compared using unpaired Student’s t-
est. For comparisons of categorical variables between
he groups, the chi-square test or Fisher’s exact test
as used as appropriate. Logistic regression models were
pplied to assess the independent effect of various clin-ith use of the log-rank test. A p-value less than 0.05
as considered statistically signiﬁcant. Statistical analy-
es were performed with SPSS (SPSS 11.0J, Chicago, IL,
SA) and StatView (StatView Version 4.5, Berkeley, CA,
SA).
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Figure 1 Representative examples of 99mTc myocardial perfusion imaging in patients with focal and non-focal defects. The
upper and middle panels show examples of non-focal group with minimally impaired perfusion (A) and multiple small defects
(B). Left = short-axis views; middle = vertical long-axis views; right = horizontal long-axis views. See text for details.
Results
Representative examples of myocardial perfusion pattern,
i.e. focal and non-focal defect patterns are shown in Fig. 1.
Of 62 DCM patients, 27 patients had focal defects and
35 patients, non-focal defects. In the focal group, perfu-
sion defects were found in various areas of LV, including
antero-septal, infero-posterior, and lateral walls, and a con-
siderable number of patients with focal defect had perfusion
defects more than one area (Fig. 2). As shown in Table 1,
there were no differences in the prevalence of hypertension,
diabetes mellitus, dilated stage of HCM, or atrial ﬁbrillation
between the 2 groups.
There were no differences in echocardiographic indices
including LV end-diastolic and end-systolic dimensions and
LVEF between the 2 groups, suggesting LV systolic dys-
Figure 2 The frequency of myocardial perfusion defects in
each area of the focal group. Open bars indicate patients with
focal defects in one area, closed bars patients with those in
more than one area.
Figure 3 Comparisons of QRS duration and the frequencies
of ventricular arrhythmias between the focal and non-focal
groups. Non-sustained ventricular tachycardia (NSVT) was
assessed by Holter electrocardiogram recording; history of ven-
tricular tachycardia (VT) and ventricular ﬁbrillation (VF) was
determined by medical records.
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Table 1 Patient characteristics and clinical indices at baseline.
Non-focal defect (n = 35) Focal defect (n = 27) p-Value
Male (%) 28 (80) 16 (59) ns
Age (years) 55.5± 13.2 58.9± 16.0 ns
Hypertension 11 (31) 1 (3) ns
Diabetes mellitus 9 (26) 4 (15) ns
DHCM 7 (20) 4 (15) ns
NYHA II 21 (60) 23 (85) 0.05
Atrial ﬁbrillation 9 (26) 5 (19) ns
LBBB 2 (6) 3 (11) ns
QRS 120ms 9 (26) 14 (52) ns
Treatment
ICD 4 (11) 9 (33) ns
ACE inhibitor/ARB 29 (83) 23 (85) ns
-Blocker 9 (26) 8 (30) ns
LVEF (%) 27.9± 7.8 30.3± 9.2 ns
LVEDD (mm) 63.8± 7.5 63.4± 9.1 ns
LVESD (mm) 55.2± 7.8 54.3± 9.3 ns
Summed severity scores 5.0± 6.1 20.4± 13.6 p < 0.01
BUN (mg/dl) 17.0± 7.0 19.7± 7.0 ns
Creatinin (mg/dl) 0.88± 0.30 0.86± 0.24 ns
Hemoglobin (mg/dl) 13.8± 1.9 13.0± 1.7 ns
BNP (pg/dl) 302± 595 (n = 30) 469± 579 (n = 23) ns
BNP 200 (pg/dl) 7/30 (23) 15/23 (65) p < 0.05
NE (pg/ml) 325± 188 (n = 29) 452± 357 (n = 24) ns
NE 500 (pg/ml) 3/29 (10) 9/24 (38) p < 0.05
Figures are mean± SD or number (%) of patients. DHCM, dilated stage of hypertrophic cardiomyopathy; NYHA, New York Heart Association
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function was comparable between the groups. However,
summed severity scores of myocardial perfusion were
greater in patients with focal defect than in those with
non-focal defect (Table 1). Patients with focal defect had
NYHA functional class  II, BNP 200 pg/dl, and plasma
norepinephrine  500 pg/ml more frequently at the begin-
ning of the study compared with the non-focal group
(Table 1).
As compared with the non-focal group, the focal group
had characteristic ECG ﬁndings. That is, QRS duration was
signiﬁcantly longer, non-sustained VT was recorded more
frequently on Holter ECG recording, and VT and VF were
complicated more frequently in the focal group (Fig. 3).During a mean follow-up period of 5.3± 2.8 years, 23
patients died and 2 patients were lost to follow-up. Of 13
patients with implantable cardioverter deﬁbrillator (ICD), 6
patients received successful deﬁbrillation shock during the
i
f
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Table 2 Cardiac events in focal and non-focal groups.
Non-focal defect (n = 35)
Death 10 (29)
ICD shock 2 (6)
Death or ICD shock 10 (29)
Figures are numbers (%) of patients. Memory of implantable cardioverte
to terminate sustained ventricular tachycardia or ventricular ﬁbrillatioioverter deﬁbrillator; ACE, angiotensin-converting enzyme; ARB,
n; LVEDD, left ventricular end-diastolic dimension; LVESD, left
ype natriuretic peptide; NE, norepinephrine.
ollow-up period, and they were deﬁned as non-survivors
t the time of deﬁbrillation shock in the following analy-
is. There were 10 non-survivors in the non-focal group and
4 non-survivors in the focal groups, and the mortality was
igher in the focal group (Table 2). Logistic regression anal-
sis was performed to determine the independent effect on
urvival of clinical characteristics including age, sex, NYHA
unctional class, echocardiographic indices, and QRS dura-
ion. Age 65 years, LVEF < 30%, and QRS duration 120ms
merged as independent predictors of mortality (Table 3).
he scintigraphic pattern of focal defect did not reach sta-
istical signiﬁcance when it was included in the logistic
egression analysis, but the above 3 factors remained to be
ndependent predictors. As shown in Fig. 4, patients with
ocal defect had worse survival than those with non-focal
efect, despite LV systolic dysfunction being comparable
etween the 2 groups.
Focal defect (n = 25) p-Value
13 (52) p = 0.07
4 (16) ns
14 (56) p < 0.05
r deﬁbrillator (ICD) indicated shocks were delivered appropriately
n.
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Table 3 Univariate and multivariate analyses of determinants of mortality.
Univariate analysis Multivariate analysis
OR CI p-Value OR CI p-Value
Male sex 0.46 0.15—1.44 0.185 — — —
Age 65 years 3.24 1.07—9.83 0.038 5.45 1.31—22.76 0.020
NYHA II 4.32 1.08—17.22 0.038 1.77 0.34—9.12 0.493
LVDDs 60 mm 1.84 0.55—6.14 0.320 — — —
LVEF 30% 0.22 0.07—0.74 0.014 0.17 0.04—0.77 0.022
QRS 120ms 3.90 1.28—11.92 0.017 5.32 1.30—21.75 0.020
OR, odds ratio; CI, 95% conﬁdential interval; NYHA, New York Heart Association; LVEDD, left ventricular end-diastolic dimension; LVEF,
left ventricular ejection fraction.
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LV systolic function as expressed by LVEF and LV end-diastolicigure 4 Kaplan—Meier survival curves of the focal and non-
ocal groups.
iscussion
ajor ﬁndings of the present study were as follows. First,
on-ischemic DCM patients with moderate to severe LV
ysfunction had various patterns of myocardial perfusion
maging, and more than 40% of these patients had focal per-
usion defect. Second, patients with focal defect had more
evere heart failure symptoms, more frequent ventricular
achyarrhythmias, and worse prognosis compared to those
ith minimally impaired perfusion or multiple small defects,
espite LV systolic dysfunction being comparable between
hese groups.
erfusion imaging in DCM patients
on-ischemic DCM is typically associated with global eccen-
ric LV hypertrophy, increased LV volume, and reduced LV
ystolic function. However, heterogeneity in regional LV
unction has been demonstrated in patients with DCM;
he pattern of heterogeneity widely varied among these
atients, i.e. reduced function in the inferior, septal, or
nterior walls, but preserved function typically in the lat-
ral and basal walls [1—4,13]. Similarly, several patterns
f myocardial perfusion imaging were reported in patients
ith DCM [9]. Many possibilities have been proposed as
a
n
p
hhe mechanism or mechanisms responsible for heteroge-
eous myocardial perfusion in DCM patients [14—17]. Among
hem are partial-volume effect due to reduced wall thicken-
ng, down-regulated perfusion secondary to reduced oxygen
emand, increased intramyocardial pressure during dias-
ole, and ﬁbrotic alterations. The severity of 201Tl perfusion
efect was strongly related with advancement of myocar-
ial ﬁbrosis in patients with DCM [18]. Other investigators
19], however, found that the ventricular wall was thin and
o ﬁbrosis was observed at the site of 201Tl defect in patients
ith DCM.
A total of 11 of 62 patients in the present study suf-
ered from dilated stage of HCM. A previous study [20] has
hown that patients with HCM often have exercise-induced
eversible or ﬁxed defect in myocardial perfusion scinti-
ram even in the absence of associated coronary artery
isease. The hypoperfusion may be explained by regional
mbalance in myocardial oxygen supply-demand, microvas-
ular disease, or systolic compression of coronary artery in
hese patients with HCM [21]. In the present study, however,
he frequency of patients with dilated stage of HCM did not
iffer between the focal and non-focal groups. Thus, the
recise mechanism of perfusion abnormality observed in our
atients with non-ischemic DCM remains unclear.
Wallis et al. [11] showed that DCM patients with segmen-
al LV wall motion abnormality had better prognosis associ-
ted with lower LV end-diastolic dimension and greater LVEF
ompared to those with diffuse wall motion abnormality.
amaguchi et al. [22] also reported that DCM patients with
iffuse LV wall motion abnormality had more elevated LV
nd-diastolic pressure and a trend to greater LV end-diastolic
olume compared to those with segmental wall motion
bnormality despite similar LVEF between these 2 groups.
hey also found a correlation between a reduced 201Tl
ptake and regional wall motion abnormality within the left
entricle [22]. In contrast, other investigators [10] showed
hat segmental wall motion abnormality was frequently
bserved in DCM and was associated with more severe sys-
olic dysfunction and worse prognosis. In the present study,nd systolic dimensions was similar between the focal and
on-focal groups, but patients with focal defect had worse
rognosis in association with more severe symptoms and
igher levels of neurohumoral factors compared to the non-
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focal group. Regional LV wall motion, which might have
affected the worse clinical outcome in the focal defect
group, was not evaluated in the present study. A consider-
able number of DCM patients had late gadolinium enhance-
ment with cardiovascular magnetic resonance (CMR),
especially in midwall enhancement which was similar to the
ﬁbrosis found at autopsy [23]. The late enhancement with
CMR predicted adverse cardiac outcome, and also predicted
interventricular systolic dyssynchrony in patients with DCM
[24—26]. We did not perform a CMR study, but patients with
focal defect might have more severe ﬁbrosis and ventricular
dyssynchrony than those with non-focal defect.
In patients with heart failure, QRS duration correlates
inversely with LV contractile function as indexed by the max-
imal rate of pressure rise [27,28]. Previous studies [29,30]
showed that QRS duration might be a marker of high risk
in patients with DCM. In the present study, QRS duration
was longer in the focal group than in the non-focal group
and multivariate analysis actually indicated QRS duration 
120ms was an independent risk factor for the non-survivors.
Fibrosis in the area of focal perfusion defect might be associ-
ated with intraventricular conduction delay, thereby leading
to intraventricular dyssynchrony. A failing heart accompa-
nied by LV dyssynchrony might have severely impaired LV
diastolic function due to prolonged systolic intervals and
dyssynchronous relaxation and also reduced energy efﬁ-
ciency or metabolic alterations compared to a failing heart
without LV dyssynchrony [31,32]. Therefore, a failing heart
with focal perfusion defect and LV dyssynchrony may result
in worse hemodynamic conditions as compared to that with-
out focal perfusion defect or dyssynchrony, even if both
hearts have similar LVEF and LV dimensions. LV with focal
perfusion defect due to myocardial ﬁbrosis might be asso-
ciated with arrhythmia substrate and, might be at risk for
ventricular arrhythmias [33].
Limitations
The present study was limited for several reasons. First, we
did not determine regional LV wall motion abnormality, but
just determined LV end-diastolic and end-systolic dimen-
sions and EF. Therefore, it was obscure whether patients
with focal perfusion defect actually had heterogeneous LV
contraction, i.e. LV dyssynchrony or not. However, pre-
vious studies [1—5] have clearly shown in patients with
DCM that heterogeneity of LV contraction exists commonly
and focal perfusion defect is associated with regional wall
motion abnormalities. Second, the present study was ret-
rospectively performed and patients were divided into 2
groups according to visual assessment of SPECT images but
not to quantitative assessment. The inﬂuences of myocar-
dial perfusion images assessed by quantitative analysis on
prognosis in patients with DCM should be prospectively stud-
ied, although the use of renin-angiotensin system inhibitors
or -blockers has improved the prognosis of DCM patients
[34].In summary, patients with DCM had various patterns in
myocardial perfusion images and were frequently associated
with focal perfusion defect despite no signiﬁcant coronary
artery stenosis. Focal perfusion defects may be a marker of
worse prognosis in patients with non-ischemic DCM.
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